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In mid-May 2007, a respiratory disease outbreak as-
sociated with adenovirus, serotype B14 (Ad14), was rec-
ognized at a large military basic training facility in Texas. 
The affected population was highly mobile; after the 6-week 
basic training course, trainees immediately dispersed to ad-
vanced training sites worldwide. Accordingly, enhanced sur-
veillance and control efforts were instituted at sites receiving 
the most trainees. Specimens from patients with pneumo-
nia or febrile respiratory illness were tested for respiratory 
pathogens by using cultures and reverse transcription–PCR. 
During May through October 2007, a total of 959 specimens 
were collected from 21 sites; 43.1% were adenovirus posi-
tive; the Ad14 serotype accounted for 95.3% of adenovirus 
isolates. Ad14 was identiﬁ  ed at 8 sites in California, Florida, 
Mississippi, Texas, and South Korea. Ad14 spread readily to 
secondary sites after the initial outbreak. Military and civilian 
planners must consider how best to control the spread of 
infectious respiratory diseases in highly mobile populations 
traveling between diverse geographic locations.
A
denovirus (Ad)–associated acute respiratory dis-
ease (AdARD) epidemics have been widely reported 
among recruits at US Department of Defense (DoD) train-
ing centers (1–5). Vaccines targeting Ad4 and Ad7, the 
most common serotypes associated with these illnesses, 
were used among United States military trainees from 1971 
through early 1999, when the supply was exhausted follow-
ing cessation of vaccine production in 1996 (1). Because 
of the historically high negative effects of respiratory dis-
ease and the discontinuation of vaccine, the DoD initiated 
a population-based, active surveillance program in 1996 
to track ARD activity among recruits at 8 military train-
ing centers, including the Air Force’s only recruit training 
center at Lackland Air Force Base (AFB) in San Antonio, 
Texas (1,6,7).
Lackland AFB admits 400–800 new basic military 
trainees (BMTs) per week; ≈35,000 BMTs graduate annu-
ally. BMTs are assigned to ﬂ  ights of 45–65 persons during 
the 6.5-week training program. All ﬂ  ight members train, 
eat, and sleep as a unit and are housed in 1 large open-bay 
facility. According to DoD surveillance data, during Janu-
ary 2005–January 2007 Lackland AFB experienced rela-
tively mild ARD activity among BMTs; rates ranged from 
0.1–0.7 cases per 100 recruit-weeks (US Naval Health Re-
search Center, unpub. data). No adenovirus-positive speci-
mens from Lackland AFB were serotyped during 2005, and 
only 4 were serotyped during 2006; serotypes included 1 
Ad21, 1 AdC, and 1 Ad3. One specimen showed an Ad14/
Ad21 co-infection (8). Adenovirus serotype B14 (Ad14) 
was detected at Lackland AFB for the ﬁ  rst time in 2006; 
in that same year, Ad14 was also detected at 3 other DoD 
training centers (8).
Beginning in February 2007, an outbreak of respira-
tory illness associated with Ad14 occurred among Lack-
land AFB BMTs. During the height of the outbreak in June 
2007, ARD rates exceeded 2.0 cases per 100 recruit-weeks 
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(Naval Health Research Center, unpub. data). Most cases 
involved only mild, acute, febrile, respiratory illness. How-
ever, during April–October 2007, 27 patients were hospital-
ized with pneumonia and more severe sequelae; some pa-
tients required intensive care. All these patients were found 
to be adenovirus positive, and 20 (74.1%) had positive tests 
for the Ad14 subtype. The recognition of these more severe 
cases prompted an investigation and enhanced surveillance 
to describe the clinical and epidemiologic characteristics of 
Ad14 in this population. Laboratory results from early in 
the investigation indicated that 63% of ARD-related respi-
ratory specimens collected from BMTs were positive for 
adenovirus and that 90% of adenovirus infections were the 
Ad14 subtype (9). Most BMTs became ill with adenovirus 
in training weeks 4 and 5 (US Naval Health Research Cen-
ter, unpub. data) and may have still been infectious after 
graduation because virus shedding can occur in respiratory 
secretions and feces for several weeks (10–12).
We modeled the transmission of Ad14 through 2 hy-
pothetical ﬂ  ights containing 50 BMTs each (Figure 1) by 
using data based on actual laboratory results and epidemio-
logic ﬁ  ndings from Lackland AFB; our model indicated 
that >50% of BMTs, during the height of the outbreak, 
were infected with Ad14 over the course of the 6.5 week 
training period (9; Naval Health Research Center, unpub. 
data). At the end of basic training, with the conservative 
assumption that recovering patients shed virus for up to 1 
month, ≈28% of BMTs were still infectious at graduation 
and in the following days or weeks. Given the likelihood 
that some BMTs were still ill or shedding Ad14 after com-
pleting basic training, response and control efforts had to 
account for the high mobility of this population.
Following graduation, students immediately dispersed 
to >130 secondary DoD sites for advanced training (Figure 
2); most went to a few large Air Force training centers in 
the United States, while a few went to smaller sites world-
wide. Secondary training sites, including Sheppard AFB 
(Wichita Falls, TX, USA), Goodfellow AFB (San Angelo, 
TX, USA), and Keesler AFB (Biloxi, MS, USA), began 
reporting increased ARD among their trainees in mid to 
late May 2007. We report the spread of Ad14 to secondary 
training installations and subsequent response efforts, fol-
lowing the Lackland AFB outbreak, from May 25 through 
October 31, 2007.
Methods
Surveillance
In late May 2007, enhanced, active ARD surveillance 
was initiated at 12 military installations that received basic 
training graduates, including 5 Air Force secondary train-
ing sites that received the most graduates from Lackland 
AFB: Sheppard AFB, (28.4% of BMT graduates); Keesler 
AFB, (16.4%); Goodfellow AFB, (3.8%); Hurlburt Field, 
Florida (1.8%); and Brooks City-Base, Texas (0.7%). In 
total, the 12 sites participating in enhanced surveillance 
efforts received 54.2% of BMT graduates moving to non–
Lackland AFB sites for their secondary training.
Staff from the US Air Force School of Aerospace 
Medicine (USAFSAM) sent respiratory specimen collec-
tion kits and educational materials to the secondary sites 
that had cases, created a website to disseminate informa-
tion, and encouraged participation through regular email 
correspondence. Investigators at USAFSAM enhanced sur-
veillance efforts by directing efforts to sites with suspected 
cases but decreasing or few specimen submissions.
Nasal wash, nasopharyngeal swab, and oropharyngeal 
(OP) swab specimens were collected from patients meeting 
the ARD case deﬁ  nition May 25–October 31, 2007, and 
sent to USAFSAM in viral Universal Transport Medium 
(Copan, Brescia, Italy). The ARD case deﬁ  nition included 
fever of >100.5°F with a cough or sore throat or evidence 
of pneumonia. Routine patient surveys that accompanied 
laboratory specimens were reviewed to obtain patients’ 
demographic data, signs and symptoms, additional clinical 
information, travel history, and lost training days.
Additionally, staff from USAFSAM and the Air Edu-
cation and Training Command headquarters coordinated 
the public health response and provided guidance on pre-
vention, enhanced surveillance, and control efforts. Sites 
not included in initial enhanced surveillance efforts were 
also invited to send specimens collected from patients 
whose conditions met the case deﬁ  nition. By using labo-
ratory surveillance data, weekly ARD and AdARD trends 
were tracked at the 3 main sites reporting increased ARD, 
Sheppard AFB, Keesler AFB, and Goodfellow AFB.
Laboratory Methods
Specimens were tested by traditional viral culture, 
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Figure 1. Evolving adenovirus 
subtype B14 incidence rate 
per 100 US Air Force basic 
military trainees over 6.5 weeks 
of basic training, based on 
epidemiologic and laboratory 
surveillance data. Red circles, 
acutely ill; yellow circles, 
recovering/possibly infectious; 
blue circles, well.Spread of Adenovirus to Military Installations
shell vial culture (R-Mix; Diagnostic Hybrids, Athens, OH, 
USA), and, beginning July 25, 2007, reverse transcription–
PCR (RT-PCR) for subtype B14. Most adenovirus culture–
positive specimens submitted between May 26 and July 25, 
2007 were tested for Ad14 after the test capability became 
available. Viral and shell vial culture identiﬁ  ed adenovirus, 
inﬂ  uenza, parainﬂ  uenza viruses 1–3, respiratory syncytial 
virus, and rhinovirus, as well as herpes simplex virus 1 and 
enterovirus after additional evaluation. Tube cultures were 
examined for 10 days for cytopathologic effects, and cells 
from the shell vial cultures were stained with pooled ﬂ  uo-
rescent antibodies and virus-speciﬁ  c monoclonal antibodies. 
The procedure and hexon-speciﬁ  c oligonucleotides for the 
adenovirus B14-speciﬁ  c monoplex RT-PCR were adapted 
from a US Naval Health Research Center protocol (8,13). On 
nasal wash and OP swab specimens and adenovirus isolates, 
DNA was extracted from the transport media and ampliﬁ  ed 
by RT-PCR. The resulting RT-PCR products were then puri-
ﬁ  ed by using Millipore (Billerica, MA, USA) microcolumns 
and subsequently analyzed by agarose gel electrophoresis, 
DNA sequencing, or both. The analyte-speciﬁ  c  reagent 
(ASR) primers and laboratory-developed diagnostic assay 
were used in accordance with requirements speciﬁ  ed by the 
College of American Pathologists for use as part of molecu-
lar diagnostics testing performed at USAFSAM.
Prevention and Control
In addition to adopting prevention and control mea-
sures to mitigate transmission within its own training popu-
lation (9), Lackland AFB ofﬁ  cials initiated actions to re-
duce spread to secondary training sites. Personnel screened 
outgoing BMTs from Lackland AFB for fever by placing 
chemical temperature dots on the forehead. Students with 
a temperature >100.5°F were held back from travel and 
housed in a medical-hold dormitory until their measured 
temperatures dropped below 100.5°F for 24 hours. Second-
ary training sites also adopted prevention and control mea-
sures to help incoming students and other assigned active 
duty members remain as healthy as possible.
Because it typically receives the most BMT graduates, 
Sheppard AFB instituted more aggressive case-ﬁ  nding pro-
cedures and prevention measures than any other secondary 
training site and fully implemented these actions by June 
8, 2007, 12 days after enhanced surveillance efforts began. 
Their prevention efforts are described here; several other 
secondary sites instituted similar practices. All students ar-
riving from Lackland AFB were screened for a measured 
fever >100.5°F and administered a questionnaire during in-
processing. Students suspected of having ARD were fur-
ther screened by a healthcare provider and sent to the clinic 
for treatment and testing as appropriate. Students with 
ARD were issued masks, grouped with other ARD stu-
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Figure 2. Locations of military sites that received US Air Force 
basic military training graduates for secondary training in North 
America (A), the Paciﬁ  c region (B), and Europe and the Middle 
East (C). Red indicates locations that submitted specimens as part 
of adenovirus surveillance. Star in panel A indicates Lackland Air 
Force Base, Texas, USA. Maps generated by using TerraMetrics 
(www.terrametrics.com).RESEARCH
dents, placed on quarters (conﬁ  ned to their living area and 
restricted from participating in all work and leisure activi-
ties), and removed from all training activities. Students on 
quarters were not allowed to enter dining halls, and meals 
were instead brought to their rooms. Students were reevalu-
ated by a healthcare provider after 24 hours on quarters and 
returned to duty if afebrile.
Sheppard AFB mandated that a virucidal cleaning 
agent be used several times per day to sanitize high-touch 
surfaces in facilities, including dining halls, classrooms, 
dormitories, buses, taxis, the post ofﬁ  ce, and other student-
frequented establishments. In addition, hand washing and 
use of hand sanitizer were highly encouraged and closely 
monitored.
Upon completion of the training program, outgoing 
students were also screened for ARD by using the same 
questionnaire and a documented temperature. All students 
suspected of having ARD were placed on medical hold and 
evaluated by a physician to determine whether treatment 
was needed. After 24 hours they were reevaluated and re-
leased to travel if afebrile.
Results
From May 25 through October 31, 2007, USAFSAM 
received 959 respiratory specimens from the 12 secondary 
training sites that initially participated in enhanced sur-
veillance and from 9 additional sites (Table 1). Adenovi-
rus accounted for 413 (89.8%) of the 460 specimens with 
known etiologic agents; the other viruses identiﬁ  ed includ-
ed parainﬂ  uenza (31 [6.7%]), inﬂ  uenza type A (5 [1.1%]), 
respiratory syncytial virus (2 [0.4%]), and enterovirus (1 
[0.2%]). Among the specimens that were culture posi-
tive for adenovirus, 358 (86.7%) were tested for Ad14, of 
which 341 (95.3%) were positive. Ad14 was identiﬁ  ed at 8 
secondary sites located in California, Florida, Mississippi, 
Texas, and South Korea; collection dates of the ﬁ  rst Ad14-
positive specimen at each site ranged from May 30 through 
October 30. Most patients (331 [97.1%]) with conﬁ  rmed 
Ad14 infection were advanced training students, while 9 
(2.6%) infections occurred in active duty members outside 
the training population, and 1 (0.03%) occurred in a depen-
dent child.
Patient survey data were available for 538 of the 959 
(56.1%) patients from whom specimens were collected; 
of these, 220 (40.9%) were Ad14 positive. The follow-
ing results are only for those 220 patients with conﬁ  rmed 
Ad14 infection and available patient survey data (Table 
2). Patient ages spanned 17–29 years, though most (183 
[84.7%]) patients were 18–22 years of age; the median age 
was 19 years. In addition, most (197 [89.5%]) patients were 
male. Regarding patient symptoms, the median tempera-
ture recorded was 101.0°F. The most common signs and 
symptoms reported by patients were sore throat (90.9%), 
chills (83.2%), fatigue (78.6%), cough (78.2%), head-
ache (75.9%), body aches (70.0%), and nasal congestion 
(61.4%). One patient was hospitalized with pneumonia 
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Table 1. Summary of results from respiratory specimens received from USAF secondary training bases, May 25–October 31, 2007* 
Site†
No.
specimens
Adenovirus not otherwise 
specified, no. (%)  Ad14, no. (%) 
Date first Ad14-positive 
specimen collected 
Altus AFB, OK  2 0 0 –
Andrews AFB, MD  12 1 (8)  0 –
Bolling AFB, DC  1 0 0 –
Brooks City-Base, TX  10 1 (10)  1 (100)  Jun 30
Goodfellow AFB, TX  71 37 (52)  19 (51)  Jun 1
Hurlburt Field, FL  3 2 (67)  2 (100)  Oct 22 
Keesler AFB, MS  85 46 (54)  38 (83)  May 31 
Laughlin AFB, TX  11 2 (18)  0 –
Luke AFB, AZ  3 1 (33)  0 –
Maxwell AFB, AL  23 1 (4)  0 –
Nellis AFB, NV  3 0 0 –
Osan AB, South Korea  6 1 (17)  1 (100)  Jun 19 
Patrick AFB, FL  2 0 0 –
Randolph AFB, TX  9 1 (11)  1 (100)  Oct 30 
Scott AFB, IL  9 2 (22)  0 –
Sheppard AFB, TX  683 309 (45)  273 (88)  May 30 
Tinker AFB, OK  6 2 (33)  0 –
USAF Academy, CO  6 0 0 –
Vance AFB, OK  0 0 0 –
Vandenberg AFB, CA  10 7 (70)  6 (86)  Jun 14 
Wright-Patterson AFB, OH  4 0 0 –
Total 959 413 (43)  341 (83) 
*USAF, United States Air Force; Ad14, adenovirus B14; AFB, Air Force Base; OK, Oklahoma; MD, Maryland; DC, District of Columbia; TX, Texas; FL, 
Florida; MS, Mississippi; AZ, Arizona; AL, Alabama; NV, Nevada; AB, Air Base; IL, Illinois; CO, Colorado; CA, California; OH, Ohio.  
†All sites located in the United States except Osan AB (South Korea). Spread of Adenovirus to Military Installations
and recovered fully without complications. A total of 191 
(86.8%) patients were placed on quarters. Of the 125 pa-
tients for whom length of quarters information was avail-
able, most (108 [86.4%]) were placed on quarters for 24 
hours. In addition, 147 (66.8%) patients had recently trav-
eled; of these, most (143 [97.3%]) had recently traveled 
from Lackland AFB.
At the 3 secondary sites receiving the most BMT grad-
uates, Sheppard AFB, Goodfellow AFB, and Keesler AFB, 
AdARD incidence rates among active duty personnel were 
tracked and compared with concurrent rates calculated at 
Lackland AFB (Figure 3). AdARD rates at Lackland AFB 
ranged from 0.1–2.0 cases per 100 personnel, with 2 peaks 
in June and September 2007. AdARD activity at Sheppard 
AFB waxed and waned throughout the surveillance period, 
ranging from 0.2–0.8 ARD cases per 100 personnel. The 
largest peak of activity occurred on September 22, 2007, 2 
weeks following the onset of Lackland AFB’s second wave 
of activity. However, this AdARD activity was short lived, 
decreasing over a course of 4 weeks to 0.2 cases per 100 
personnel. Activity at Goodfellow AFB and Keesler AFB 
was highest following the initial peak at Lackland AFB, and 
then tapered off. All 3 sites placed ill students on quarters, 
which resulted in the short-term removal of >600 students 
from training activities. Only 1 person required hospital-
ization for adenovirus-associated pneumonia, at Sheppard 
AFB, during this time (0.01/100 trainees for this 23-week 
time period). As of October 31, 2007, prevention and con-
trol efforts were terminated at Goodfellow AFB and Kee-
sler AFB but continued at Sheppard AFB.
Discussion
Ad14 spread readily to secondary training sites because 
of the rapid mobility of BMTs following their graduation 
from basic training. For the most part, the onset of Ad14-
related illness occurred ﬁ  rst at sites that received the most 
BMT graduates. Although Lackland AFB made a concert-
ed effort to identify and segregate outgoing febrile BMTs, 
more than one quarter of the trainees were likely shedding 
virus or recovering from illness. In addition, many were 
possibly preclinical and incubating adenovirus as they de-
parted Lackland AFB, with illness developing shortly after 
arrival at secondary sites.
Although Ad14 was exported continuously to the sec-
ondary sites, neither the ARD rates nor the severity of ill-
ness at those sites reached the levels seen at Lackland AFB. 
Control efforts by Lackland AFB that placed febrile BMTs 
on medical hold and prevented them from leaving the base 
seemed to affect severity of illness at Lackland AFB and 
likely reduced the number of ill persons arriving at second-
ary sites. The lower rates of illness at secondary sites may 
also have been due to a decreased number of susceptible 
persons in the secondary training population, berthing dif-
ferences that resulted in less contact between trainees at 
secondary sites, and decreased stress levels among trainees. 
Additionally, decreased illness severity at the secondary 
training sites may have resulted from the early identiﬁ  ca-
tion of patients with suspected cases and their placement 
on quarters, allowing for rest and recovery. Illness trends 
at Sheppard AFB tracked Lackland AFB ARD activity 
most closely, possibly because Sheppard AFB received the 
largest proportion of BMT graduates compared with other 
secondary training sites and because healthcare personnel 
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Table 2. Demographic data, symptoms, and other information 
collected from 220 patients with positive test results for 
adenovirus serotype B14, May 25–October 31, 2007* 
Parameter Value
Median age, y (range), n = 216  19 (17–29) 
Gender 
 F  23  (10.5) 
 M  197  (89.5) 
Base where stationed 
  Goodfellow AFB, TX  8 (3.6) 
  Hurlburt Field, FL  2 (0.9) 
  Keesler AFB, MS  16 (7.3) 
  Sheppard AFB, TX  188 (85.5) 
  Vandenberg AFB, CA  6 (2.7) 
Signs and symptoms 
  Body aches  154 (70.0) 
  Chest pain  38 (17.3) 
 Chills  183  (83.2) 
 Conjunctivitis  24  (10.9) 
 Cough  172  (78.2) 
 Diarrhea  42  (19.1) 
 Dyspnea  36  (16.4) 
 Earache  60  (27.3) 
 Fatigue  173  (78.6) 
 Headache  167  (75.9) 
 Runny  nose  93  (42.3) 
  Sinus congestion  135 (61.4) 
  Sore throat  200 (90.9) 
 Stiffness  89  (40.5) 
 Vomiting  39  (17.7) 
Median clinical temperature  101°F 
Placed on quarters   191 (86.8) 
Time on quarters, n = 125 
  24 h  108 (86.4) 
  48 h  13 (10.4) 
  72 h  4 (3.2) 
Hospitalized  1 (0.5) 
Received influenza vaccine   68 (30.9) 
Recent travel  147 (66.8) 
Recent travel locations, n = 147 
  Lackland AFB, TX  143 (97.3) 
  Keesler AFB, MS  2 (1.3) 
 Albuquerque,  NM  1  (0.7) 
  Panama City, FL  1 (0.7) 
*Values are no. (%) except as specified. Complete information not 
available for all patients; n values given when below 220. All locations in 
United States. AFB, Air Force Base; TX, Texas; FL, Florida; MS, 
Mississippi; CA, California; NM, New Mexico.  RESEARCH
at that base more aggressively identiﬁ  ed cases and submit-
ted specimens. Keesler AFB and Goodfellow AFB experi-
enced an earlier decline of infection rates due partially to 
a lower inﬂ  ux of BMTs from Lackland and partially due 
to lessening participation in enhanced surveillance efforts 
after the ﬁ  rst 3–4 weeks of surveillance. Adenovirus rates 
mirrored the overall ARD rates, which suggests that ad-
enovirus accounted for most of the ARD cases during the 
entire period. As of October 31, 2007, ARD rates had sub-
sided somewhat but not sufﬁ  ciently to cease surveillance 
and control efforts.
Surveillance ﬁ  ndings indicated that spread of Ad14 to 
active duty members and dependents outside the training 
population was minimal, although surveillance efforts were 
not as robust in these populations. Because secondary train-
ing students are segregated from the base population at in-
stallations, limited contact takes place between trainees and 
other military members and their dependents. Still, the lack 
of spread of this readily transmissible pathogen to persons 
outside the training population was remarkable.
Eliminating the spread from Lackland AFB to sec-
ondary training sites was difﬁ  cult, because any control 
measures deployed had to operate within the constraints 
of the recruit training system. Particularly in wartime, 
military operational requirements do not permit slowing 
or canceling the training of new military recruits. Even 
within this limited setting, segregating ill patients and 
checking students for fever both before leaving Lackland 
AFB and upon arrival at their next duty station seemed 
to affect transmission, because ARD rates remained rela-
tively low at secondary training sites and peak ARD activ-
ity did not persist.
A new vaccine for Ad4 and Ad7 is currently under de-
velopment; phase III has been completed (14). The degree 
of cross-protection this vaccine will offer against Ad14 
is unknown, although evidence suggests some protection 
can be expected. Findings from the Lackland AFB out-
break indicated that Ad7 serum neutralizing antibody was 
protective against Ad14 illness, mitigating the severity of 
symptoms (12). Previous studies have indicated that Ad4 
and Ad7 vaccination was also protective against Ad3 (8,15) 
and Ad14 (8,15–18). Thus, implementing the Ad4 and Ad7 
vaccine may affect AdARD rates in general in future mili-
tary trainees.
Following the loss of the Ad4 and Ad7 vaccines, the 
spread of Ad4 from an Army basic training site to a sec-
ondary training installation was associated with a large 
Ad4 outbreak at a secondary site (19). In this report we 
describe the spread of Ad14 to Air Force secondary train-
ing sites by recently graduated basic trainees who moved 
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Figure 3. Rates of conﬁ  rmed adenovirus infection 
for secondary training students at Sheppard Air 
Force Base, Texas, USA (A); Goodfellow Air Force 
Base, Texas, USA (B); and Keesler Air Force Base, 
Mississippi, USA (C), compared with rates for basic 
military trainees at Lackland Air Force Base, Texas, 
USA, May 25–October 31, 2007.Spread of Adenovirus to Military Installations
quickly from Lackland AFB to their next assignment. 
Military planners must focus on how best to control the 
spread of infectious respiratory diseases in highly mobile 
military populations that travel between geographically 
dispersed locations. Additionally, these planners must 
consider that rigid public health interventions may be 
unacceptable because of interference with critical opera-
tions. In this instance, we found that interventions could 
not interfere with the ﬂ  ow of programmed training opera-
tions for a military at war. Additionally, detailed studies 
aimed at better describing the transmission of adenovirus-
es may result in better focused and more effective control 
measures. Our results show that public health leaders in 
both the military and civilian communities should be con-
cerned about the geographic spread of respiratory disease 
agents by highly mobile populations.
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